Health: pharmaceuticals; co-prescribing of naloxone with opioid drugs; require. Amends sec. 17744b of 1978 PA 368 (MCL 333.17744b).

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 7 Compare versions History 14 Sponsors

Jul 1, 2025 · Senate

REPORTED BY COMMITTEE OF THE WHOLE FAVORABLY WITH SUBSTITUTE (S-1)

Jul 1, 2025 · Senate

SUBSTITUTE (S-1) CONCURRED IN

Jul 1, 2025 · Senate

PLACED ON ORDER OF THIRD READING WITH SUBSTITUTE (S-1)

Jul 1, 2025 · Senate

RULES SUSPENDED

Jul 1, 2025 · Senate

PLACED ON IMMEDIATE PASSAGE

Jul 1, 2025 · Senate

PASSED ROLL CALL # 196 YEAS 34 NAYS 2 EXCUSED 1 NOT VOTING 0

Jul 1, 2025 · House

received on 07/01/2025

Jul 1, 2025 · House

read a first time

Jul 1, 2025 · House

referred to Committee on Insurance

Jun 26, 2025 · Senate

REFERRED TO COMMITTEE OF THE WHOLE WITH SUBSTITUTE (S-1)

Jun 26, 2025 · Senate

RULES SUSPENDED FOR IMMEDIATE CONSIDERATION

Jun 26, 2025 · Senate

REPORTED FAVORABLY WITH SUBSTITUTE (S-1) 6/25/2025

Jun 11, 2025 · Senate

INTRODUCED BY SENATOR SYLVIA SANTANA

Jun 11, 2025 · Senate

REFERRED TO COMMITTEE ON HEALTH POLICY

PASSAGE PROBABILITY

13.1% Unlikely

Why this number

Stage base Passed First Chamber — base rate 33%, measured from MI's completed sessions
Momentum +2 59/100 from the pace of recorded action
Time since last action -22 467 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.